Skip to content
2000
Volume 6, Issue 1
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Hsp90 is a chaperone with important roles in maintaining transformation and in elevating the survival and growth potential of cancer cells. Activation of signaling pathways mediated by Hsp90 protein clients is necessary for cell proliferation, regulation of cell cycle progression and apoptosis. Additionally, gain-of-function mutations responsible for transformation often require Hsp90 for the maintenance of their folded, functionally active conformations. These characteristics promise Hsp90 as an important target in cancer therapy and prompt for the identification, development and clinical translation of small molecule inhibitors of the chaperone. This review intends to update the reader on the status of several existing and emerging classes of direct inhibitors of Hsp90 ATPase activity.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152006774755483
2006-01-01
2025-06-08
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152006774755483
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test